Preclinical systolic and diastolic dysfunction assessed by tissue Doppler imaging is associated with elevated plasma

Rasmus Mogelvang1, Jens P Goetze, Sune A Pedersen

  • 1Copenhagen City Heart Study, Epidemiological Research Unit, Bispebjerg Hospital, Copenhagen, Denmark. Rasmus.Mogelvang@get2net.dk

Insights

Tissue Doppler imaging (TDI) detects early cardiac dysfunction, even before conventional echocardiography shows abnormalities. This preclinical dysfunction is linked to elevated pro-brain natriuretic peptide levels, aiding heart failure risk assessment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomarkers

Background:

  • Heart failure presents a significant public health challenge.
  • Early detection of cardiac dysfunction is crucial for improving prognosis.
  • Conventional echocardiography has limitations in identifying early dysfunction.

Purpose of the Study:

  • To evaluate the utility of Tissue Doppler Imaging (TDI) for detecting preclinical cardiac dysfunction.
  • To assess the association between TDI-derived cardiac function parameters and plasma pro-brain natriuretic peptide (proBNP) levels.

Main Methods:

  • A community-based study involving 1012 participants.
  • Cardiac function assessed using conventional echocardiography and TDI.
  • Plasma proBNP levels were measured.
  • TDI parameters included peak systolic (s') and early/late diastolic (e', a') velocities, and an eas-index.

Main Results:

  • Individuals with elevated proBNP showed significantly impaired systolic and diastolic function by TDI (lower s', a'; higher e'/a' and eas-index).
  • These findings persisted after multivariable adjustment for various clinical factors.
  • TDI provided additional predictive information beyond conventional echocardiography for elevated proBNP.

Conclusions:

  • Preclinical systolic and diastolic dysfunction, identified by TDI, correlates with elevated plasma proBNP.
  • TDI can detect cardiac dysfunction earlier than conventional echocardiography, even when other measures are normal.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...